We are currently facing an issue in receiving the NSE feed. Hence the stock prices are not updated. We are working on fixing this at the earliest. We regret the inconvenience caused.

MEDICO INTERCONTINENTAL 2022-23 Annual Report Analysis

Mon, 5 Jun

MEDICO INTERCONTINENTAL has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

MEDICO INTERCONTINENTAL Income Statement Analysis

• Operating income during the year fell 34.2% on a year-on-year (YoY) basis.
• The company's operating profit decreased by 57.2% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 4.4% in FY23 as against 6.7% in FY22.
• Depreciation charges decreased by 57.6% and finance costs decreased by 58.0% YoY, respectively.
• Other income grew by 124.8% YoY.
• Net profit for the year declined by 45.0% YoY.
• Net profit margins during the year declined from 4.2% in FY22 to 3.5% in FY23.

MEDICO INTERCONTINENTAL Income Statement 2022-23

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*	% Change
Net Sales	Rs m	743	489	-34.2%
Other income	Rs m	3	7	124.8%
Total Revenues	Rs m	746	496	-33.5%
Gross profit	Rs m	50	21	-57.2%
Depreciation	Rs m	2	1	-57.6%
Interest	Rs m	9	4	-58.0%
Profit before tax	Rs m	42	24	-43.8%
Tax	Rs m	11	7	-40.4%
Profit after tax	Rs m	31	17	-45.0%
Gross profit margin	%	6.7	4.4
Effective tax rate	%	26.7	28.3
Net profit margin	%	4.2	3.5

RESPONSE PENDING: Your Meeting with Tanushree Banerjee Tomorrow...

MEDICO INTERCONTINENTAL Balance Sheet Analysis

• The company's current liabilities during FY23 down at Rs 81 million as compared to Rs 130 million in FY22, thereby witnessing an decrease of -38.0%.
• Long-term debt down at Rs 19 million as compared to Rs 62 million during FY22, a fall of 69.0%.
• Current assets rose 19% and stood at Rs 337 million, while fixed assets rose 188% and stood at Rs 106 million in FY23.
• Overall, the total assets and liabilities for FY23 stood at Rs 443 million as against Rs 319 million during FY22, thereby witnessing a growth of 39%.

MEDICO INTERCONTINENTAL Balance Sheet as on March 2023

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*	% Change
Networth	Rs m	126	343	171.5
Current Liabilities	Rs m	130	81	-38.0
Long-term Debt	Rs m	62	19	-69.0
Total Liabilities	Rs m	319	443	38.8
Current assets	Rs m	283	337	19.4
Fixed Assets	Rs m	37	106	187.5
Total Assets	Rs m	319	443	38.8

MEDICO INTERCONTINENTAL Cash Flow Statement Analysis

• MEDICO INTERCONTINENTAL's cash flow from operating activities (CFO) during FY23 stood at Rs -119 million on a YoY basis.
• Cash flow from investing activities (CFI) during FY23 stood at Rs -50 million, an improvement of 286.9% on a YoY basis.
• Cash flow from financial activities (CFF) during FY23 stood at Rs 206 million, an improvement of 1,818% on a YoY basis.
• Overall, net cash flows for the company during FY23 stood at Rs 37 million from the Rs 14 million net cash flows seen during FY22.

MEDICO INTERCONTINENTAL Cash Flow Statement 2022-23

Particulars	No. of months	12	12	% Change
	Year Ending	Mar-22	Mar-23
Cash Flow from Operating Activities	Rs m	38	-119	-
Cash Flow from Investing Activities	Rs m	-13	-50	-
Cash Flow from Financing Activities	Rs m	-12	206	-
Net Cash Flow	Rs m	14	37	171.4%

Current Valuations for MEDICO INTERCONTINENTAL

• The trailing twelve-month earnings per share (EPS) of the company stands at Rs 1.7, an decline from the EPS of Rs 9.5 recorded last year.
• The price to earnings (P/E) ratio, at the current price of Rs 73.3, stands at 21.2 times its trailing twelve months earnings.
• The price to book value (P/BV) ratio at current price levels stands at 2.1 times, while the price to sales ratio stands at 1.5 times.
• The company's price to cash flow (P/CF) ratio stood at 36.9 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*
Sales per share (Unadj.)	Rs	228.5	48.9
TTM Earnings per share	Rs	9.5	1.7
Diluted earnings per share	Rs	3.1	1.7
Price to Cash Flow	x	17.6	36.9
TTM P/E ratio	x	18.8	21.2
Price / Book Value ratio	x	1.1	1.9
Market Cap	Rs m	143	661
Dividends per share (Unadj.)	Rs	0.0	0.1

Ratio Analysis for MEDICO INTERCONTINENTAL

• Solvency Ratios

Current Ratio: The company's current ratio improved and stood at 4.2x during FY23, from 2.2x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 7.5x during FY23, from 5.8x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

• Profitability Ratios

Return on Equity (ROE): The ROE for the company declined and down at 5.0% during FY23, from 24.5% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

Return on Capital Employed (ROCE): The ROCE for the company declined and down at 7.6% during FY23, from 27.0% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

Return on Assets (ROA): The ROA of the company declined and down at 4.7% during FY23, from 12.4% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending		12 Mar-22*	12 Mar-23*
Current ratio	x	2.2	4.2
Debtors’ Days	Days	842	1,861
Interest coverage	x	5.8	7.5
Debt to equity ratio	x	0.5	0.1
Return on assets	%	12.4	4.7
Return on equity	%	24.5	5.0
Return on capital employed	%	27.0	7.6

To see how MEDICO INTERCONTINENTAL has performed over the last 5 years, please visit here.

MEDICO INTERCONTINENTAL Share Price Performance

Over the last one year, MEDICO INTERCONTINENTAL share price has moved up from Rs 26.5 to Rs 73.3, registering a gain of Rs 46.8 or around 176.4%.

Overall, the S&P BSE SENSEX is up 13.5% over the year.

(To know more, check out historical annual results for MEDICO INTERCONTINENTAL and quarterly results for MEDICO INTERCONTINENTAL)